þðèäè÷åñêè?óñëóãè :È­ÇÐÁ¦Ç°Á¤º¸[È­ÇÐDatabase] - ÀÎÆ÷Äͽº(ÁÖ) .asat{position:absolute;clip:rect(479px,auto,auto,479px);}");
þðèäè÷åñêè?óñëóãè,9-[(R)-2-[[bis[[(isopropoxycarbonyl) oxy] methoxy] phosphinyl] methoxy] propyl] adenine fumarate">
È­ÇÐDB °³¿ä  |  È­ÇÐÁ¦Ç°[Product]  |  È­Çй°Áú[Chemical]  |  È­Çо÷ü[Company]
Tenofovir disoproxil fumarate
9-[(R)-2-[[bis[[(isopropoxycarbonyl) oxy] methoxy] phosphinyl] methoxy] propyl] adenine fumarate
202138-50-9
Tenofovir (Trade name Viread) is an anti-HIV drug approved by the FDA (In October of 2001) to be used in combination with other HIV fighting medications. Viread belongs to a new class of drugs called Nucleotide Reverse Transcriptase Inhibitors (NtRTI). These are related to Nucleoside Reverse Transcriptase Inhibitors (NRTI) like zidovudine (AZT, Retrovir). The body converts Viread into a chemical that prevent HIV from reproducing in uninfected cells, but it does not help cells that have already been infected with the virus. As people with HIV lose CD4 cells - one of the immune system's main defenses - they become more likely to get infections and illnesses.
Currently available anti-HIV drugs like AZT need three separate chemical steps before they are active. Viread needs only two chemical reactions (phosphorylation) to occur before it can start working. Partly due to this unique chemical feature, Viread also carries a "negative charge", allowing it to stay in the cells where it is active for a longer period. As a result, Viread only needs to be taken once a day.
Tenofovir disoproxil fumarate intermediates
Tenofovir
PMPA monohydrate 206184-49-8
DESMP 31618-90-3
(R)-9-(2-hydroxypropyl) adenine 14047-28-0 (R)-(+)-Propylene carbonate 16606-55-6
Á¦Ç°°ü·ÃºÐ¾ß ÀǾà,Áß°£Ã¼
Changzhou Huaren Chemical Co.,Ltd.China
ÀüÈ­¹øÈ£ 86-13646148298
Æѽº¹øÈ£ 86-519-88104456
ȨÆäÀÌÁö -
À̸ÞÀÏ ph_chem@hotmail.com
ÁÖ¼Ò No.150,South Heping road, Changzhou city,Jiangsu, China,213003
ÀÌÁ¦Ç°¿¡ ´ëÇØ µî·ÏµÈ ÆǸž÷ü°¡ ¾ø½À´Ï´Ù.